drugset / Trial / NCT00737373

Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer

NCT00737373 ↗

Phase 2 Completed 143 enrolled Krankenhaus Nordwest
RandomizedParallel-groupOpen-labelTreatment

Summary

In this trial, FLOT will be evaluated as therapy option for elderly patients (\>65 years) with advanced gastric cancer in comparison to the well established FLO scheme. The hypothesis is that FLOT is more effective than FLO in elderly patients with acceptable side effects.

Timeline

Start
2007-08
Primary completion
2009-12
Completion
2011-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule 50 mg/m2 —
Background Leucovorin Small molecule 200 mg/m2 —
Background Oxaliplatin Small molecule 85 mg/m2 —
Background fluorouracil Small molecule 2600 mg/m2 —